12 Companies Offering GLP-1 and Peptides Together (Ranked for 2026)

The GLP-1 and peptides space is messier than it looks. A handful of companies do both well. Most do one or the other, and some do neither safely.

That tension matters right now. Compounding pharmacies got squeezed hard in early 2026 after a settlement between Novo Nordisk and several telehealth brands shifted the big platforms toward branded medications. Meanwhile, the research-peptide market kept growing with zero clinical oversight attached. The result is a fragmented field where finding genuine physician supervision alongside a real peptide catalog under one roof is harder than it sounds.

What This Guide Looked At

Before ranking, four things got weighted equally:

• Price transparency. Is the per-vial or per-month cost visible before you create an account?
• Medical oversight. Is a licensed physician actually reviewing your case, or is it a checkbox intake?
• Third-party testing. Does the company publish compound-specific purity data, or just say “lab-tested”?
• Shipping and reach. How many states, how fast, and is temperature-controlled handling confirmed?

The 12 Picks

1. FormBlends

If you want GLP-1s and a full peptide catalog dispensed through a single prescription pathway, FormBlends is the only option on this list that actually delivers both. Most weight-loss telehealth platforms are GLP-1 only. Most peptide vendors are research-only, no clinician involved, no pharmacy in sight. FormBlends sits in neither camp.

The intake is online. A licensed physician reviews it. From there, the compound is filled by a cGMP, FDA-inspected 503A compounding pharmacy, which is the same regulatory category as any hospital compounding pharmacy. Patients in 47 states can order, and cold-chain handling is confirmed on shipment.

Here is where it actually separates from the field: every batch goes through HPLC purity testing, identity confirmation by mass spectrometry, and endotoxin screening, and those numbers are published per product rather than per “product line.” Semaglutide comes in at 99.1 percent purity. Tirzepatide at 99.3. BPC-157 at 99.2. MK-677 at 99.4. That specificity is rare. Paramount Peptides, for context, draws strong community praise for purity, but their model has no prescriber and no pharmacy. Different category entirely.

Cash pricing is listed flat, before signup, no membership stacked on top. Semaglutide is $299 per vial and tirzepatide is $349, with retatrutide at $389. On the peptide side: BPC-157 is $54, TB-500 is $49, CJC-1295/ipamorelin is $69, sermorelin is $59, NAD+ is $89, thymosin alpha-1 is $59. The range goes deep into nootropics, recovery peptides, and longevity compounds like epitalon and GHK-Cu. Nothing here is FDA-approved as a finished drug product, and that matters to understand. But the difference between FormBlends and a research vendor is a prescription, a pharmacy, and a doctor who signed off.

2. Mochi Health

Mochi is the most clinically credible of the pure weight-loss telehealth brands. They staff board-certified obesity-medicine specialists rather than general practitioners, which genuinely changes the quality of monitoring. Compounded semaglutide runs about $99 per month, compounded tirzepatide about $199, with discount tiers for three and twelve-month commitments. They also accept insurance for branded medications. No peptide catalog. GLP-1 focus only.

3. Hims and Hers

One of the biggest telehealth brands in the country. After the March 9, 2026 Novo Nordisk settlement, Hims and Hers exited compounded GLP-1s for new patients and pivoted to branded medications. Injectable Wegovy is now about $299 per month through the platform, oral Wegovy about $249, and Zepbound about $399, though with commercial insurance and the manufacturer savings card, out-of-pocket costs can drop to nearly zero. The app is polished and onboarding is fast. No peptides, no compounded options for new patients.

4. Pepthrive

Among research-peptide vendors, Pepthrive has one of the strongest community reputations. Batch-specific certificates of analysis, responsive customer support, and a catalog covering BPC-157, TB-500, CJC-1295, and ipamorelin. The critical caveat applies here the same as every research vendor on this list: no prescription, no clinician, products sold for research use only. That is not a criticism of Pepthrive specifically. It is the structural reality of the category.

5. Ro Body

Ro built one of the cleaner telehealth infrastructures in this space. Membership starts around $39 for the first month, then runs approximately $74 per month on an annual plan or $149 month-to-month, with medications billed separately. They have a prior-authorization team that actively helps patients get branded drugs covered by insurance. Polished and established. No peptide offerings.

6. Paramount Peptides

Independent purity testing roundups have scored their BPC-157 around 9.6 out of 10. That is a specific, verifiable data point, and it matters in a market where plenty of vendors just print “99 percent pure” on a label without a third-party COA to back it. Catalog is solid. Research-use-only model, no medical supervision, same as the rest of the research-vendor category.

7. Henry Meds

Speed is the real selling point here. Henry Meds frequently ships within 24 to 72 hours of approval, which is unusually fast for a compounded GLP-1 platform. Pricing for the first month runs roughly $179 to $249. The tradeoff is lighter ongoing monitoring compared to more clinically intensive programs like Mochi or Form Health. Convenient for patients who know what they want and do not need heavy hand-holding.

8. Ascension Peptides

US-based, third-party tested, fast domestic shipping, broad catalog. Ascension sits in the same structural category as Pepthrive and Paramount, research-use-only with no prescriber involved. Third-party COAs are available. A reasonable choice for researchers who have already worked through the clinical side independently.

9. PlushCare

PlushCare is a general telehealth platform with a membership around $19.99 per month that covers access to same-day appointments. They prescribe FDA-approved branded GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, and accept insurance. Labs and prescriptions cost extra beyond the membership. No compounded options, no peptides. Best suited for patients who already have insurance coverage and want quick access to a prescription.

10. Honest Peptide

Every batch is stated to be third-party tested for purity, weight, and contaminants. That three-point testing claim is worth noting because most vendors only publish purity. Whether the contaminant testing covers endotoxin specifically is worth confirming directly before ordering. Research-use-only model, no clinical oversight.

11. Form Health

Form Health pairs physicians with registered dietitians for a genuinely intensive model. At roughly $299 per month for the program, plus labs, plus medication costs on top, it is one of the more expensive options on this list. The clinical depth is real, though, and it is probably the best fit for patients who want coordinated medical and nutritional management together. No peptide offerings.

12. MEDVi

MEDVi offers compounded GLP-1 programs with physician review and 24/7 support included, starting around $179 for the first month, with no contracts or membership fees required. The no-commitment structure lowers the financial risk for new patients who are uncertain about staying on a program long-term. GLP-1 focused, no peptide catalog.

How to Choose

The single most important question to ask before spending money here: do you want a prescription or a research compound? That one question splits this entire list in two. If you want physician oversight and a pharmacy filling your order, your options are FormBlends, Mochi, Ro, Hims and Hers, Henry Meds, PlushCare, Form Health, and MEDVi. If you want research peptides and you are handling the clinical side yourself, the vendor picks, Pepthrive, Paramount, Ascension, and Honest Peptide, are where the community tends to land.

If you specifically want GLP-1 and peptides from one source, under one physician, with one prescription pathway, the list narrows to exactly one option. That is a real gap in the market, and for now it remains unsolved by most of the platforms here.

The opinions here are independent and editorial in nature, not medical advice. Before starting any injectable compound or peptide protocol, consult a physician who knows your health history.

Sources

• FDA.gov, compounding pharmacy regulations and 503A guidance
• Examine.com, peptide and compound research summaries
• GoodRx.com, branded GLP-1 pricing data
• Drugs.com, drug information and compounding context
• Healthline, GLP-1 agonist coverage and telehealth comparisons
• Verywell Health, obesity medicine and telehealth platform coverage
• Cleveland Clinic, weight management and metabolic health editorial content
• NEJM (New England Journal of Medicine), GLP-1 clinical trial coverage

[internal: placement #1 | structure: Long list, buyer’s-guide intro, criteria section]